{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:39:28Z","timestamp":1784651968050,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiovascular diseases (CVD) due to atherosclerosis have become one of the major causes of death among people living with HIV (PLHIV) since effective antiretroviral therapy (ART) has been available throughout the world. However, the epidemiologic evidence of this problem from the Asia-Pacific region remains unclear. We conducted a systematic review of the situation and risk factors for CVD among PLHIV in countries with the greatest impact of CVD attributable to HIV in the Asia-Pacific region.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search in PubMed\/MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews databases for articles published before 2019 was conducted. Publications reported situations and risk factors both traditional and HIV-specific for CVD among PLHIV in the region were included. Two reviewers working on duplicate and quality assessments, independently extracted data, and thematically analyzed the data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among PLHIV, the prevalence of subclinical CVD ranged from 10 to 28% and the incidence rate of clinical CVD ranged from 0.37 to 1.17 \/100 person-years. Clinical CVD was frequently observed in the early era of the highly active antiretroviral therapy. A higher prevalence of subclinical CVD such as abnormal cIMT and carotid plaques was frequently observed in the PLHIV rather than in the nonHIV population and a high proportion of early onset of CVD was found among young PLHIV adults. The traditional risk factors for CVD such as hypertension, diabetes and smoking behavior were prevalent in both PLHIV and nonHIV populations ranging from 5 to 45%. HIV-specific risk factor, and lower CD4 presented almost twice the significantly increased risks for CVD while the synergistic interaction among traditional risk factors, i.e., diabetes mellitus, dyslipidemia and family history steeply increased the risk for CVD among PLHIV by almost 20 times.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The limited existing data suggested the risk of early CVD among PLHIV. We identified the crucial gaps in HIV\/CVD work from the Asia-Pacific region and recommended longer prospective studies with larger sample sizes or meta-analyses to better capture CVD risk and interactions of crucial risk factors of this vulnerable population in this region.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Registration number<\/jats:title>\n                <jats:p>INPLASY202290108 (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/inplasy.com\/inplasy-2022-9-0108\/\">https:\/\/inplasy.com\/inplasy-2022-9-0108\/<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-15321-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:28:34Z","timestamp":1679862514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review"],"prefix":"10.1186","volume":"23","author":[{"given":"Witchakorn","family":"Ruamtawee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathuros","family":"Tipayamongkholgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnaree","family":"Aimyong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weerawat","family":"Manosuthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"issue":"3","key":"15321_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/jac\/dkm499","volume":"61","author":"RW Burgoyne","year":"2008","unstructured":"Burgoyne RW, Tan DHS. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. J Antimicrob Chemother. 2008;61(3):469\u201373. https:\/\/doi.org\/10.1093\/jac\/dkm499.","journal-title":"J Antimicrob Chemother"},{"key":"15321_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.07.026","author":"C Liao","year":"2018","unstructured":"Liao C, Yang C, Chen P, Ou H, Toh HS, Chen Z, Ko N. Direct medical costs associated with cardiovascular diseases among the HIV-infected patients in Taiwan: a population-based study. Value in Health. 2018. https:\/\/doi.org\/10.1016\/j.jval.2018.07.026.","journal-title":"Value in Health"},{"issue":"11","key":"15321_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","volume":"138","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, et al. Global Burden of Atherosclerotic Cardiovascular Disease in People living with HIV. Circulation. 2018;138(11):1100\u201312.","journal-title":"Circulation"},{"issue":"7","key":"15321_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","volume":"15","author":"M Smit","year":"2015","unstructured":"Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"15321_CR5","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","volume":"69","author":"A Kearns","year":"2017","unstructured":"Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated atherosclerosis: unraveling the Missing Link. J Am Coll Cardiol. 2017;69(25):3084\u201398.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"15321_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","volume":"4","author":"E Nou","year":"2016","unstructured":"Nou E, Lo J, Hadigan C, Grinspoon SK. Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol. 2016;4(7):598\u2013610.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"15321_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jacc.2016.09.979","volume":"69","author":"A Vachiat","year":"2017","unstructured":"Vachiat A, McCutcheon K, Tsabedze N, Zachariah D, Manga P. HIV and Ischemic Heart Disease. J Am Coll Cardiol. 2017;69(1):73\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"15321_CR8","doi-asserted-by":"crossref","unstructured":"Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS et al. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: a Scientific Statement From the American Heart Association.Circulation. 2019:CIR0000000000000695.","DOI":"10.1161\/CIR.0000000000000695"},{"issue":"12","key":"15321_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","volume":"16","author":"PY Hsue","year":"2019","unstructured":"Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16(12):745\u201359.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"15321_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.tcm.2017.06.005","volume":"27","author":"F Ballocca","year":"2017","unstructured":"Ballocca F, D\u2019Ascenzo F, Gili S, Grosso Marra W, Gaita F. Cardiovascular disease in patients with HIV. Trends Cardiovasc Med. 2017;27(8):558\u201363.","journal-title":"Trends Cardiovasc Med"},{"key":"15321_CR11","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS Data. 2019 Available at: http:\/\/rstesa.unaids.org\/publications\/global-publications\/2019\/item\/208-unaids-data-2019. Accessed on April 6, 2022."},{"issue":"Suppl 1","key":"15321_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/QAD.0000000000001888","volume":"32","author":"P Patel","year":"2018","unstructured":"Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS. 2018;32(Suppl 1):5\u2013S20.","journal-title":"AIDS"},{"issue":"3","key":"15321_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11904-018-0400-5","volume":"15","author":"K So-Armah","year":"2018","unstructured":"So-Armah K, Freiberg MS. HIV and Cardiovascular Disease: update on clinical events, special populations, and novel biomarkers. Curr HIV\/AIDS Rep. 2018;15(3):233\u201344.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"15321_CR14","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"issue":"15","key":"15321_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of Observational Studies in Epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008\u201312. https:\/\/doi.org\/10.1001\/jama.283.15.2008.","journal-title":"JAMA"},{"key":"15321_CR16","unstructured":"Higgins JPT, Green S, editors, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org."},{"key":"15321_CR17","unstructured":"Landman AJEMC, Don EE, Vissers G, Ket HCJ, Oudijk MA, de Groot CJM et al. Modified Newcastle Ottawa quality assessment scale and AHRQ standards. [Internet]. PLOS ONE; 2022 [cited 2022Sep13]. Available from: https:\/\/plos.figshare.com\/articles\/journal_contribution\/Modified_Newcastle_Ottawa_quality_assessment_scale_and_AHRQ_standards_\/19965756\/1"},{"key":"15321_CR18","doi-asserted-by":"publisher","unstructured":"Nou E, Lo J, Hadigan C, Grinspoon SK. Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol. 2016 Jul;4(7):598\u2013610. https:\/\/doi.org\/10.1016\/S2213-8587(15)00388-5.","DOI":"10.1016\/S2213-8587(15)00388-5"},{"key":"15321_CR19","doi-asserted-by":"crossref","unstructured":"Karim B, Wijaya IP, Rahmaniyah R, Ariyanto I, Waters S, Estiasari R et al. Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART.AIDS research and therapy. 2017; 14(1).","DOI":"10.1186\/s12981-017-0180-9"},{"issue":"3","key":"15321_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1468-1331.2006.01178.x","volume":"13","author":"K Subsai","year":"2006","unstructured":"Subsai K, Kanoksri S, Siwaporn C, Helen L, Kanokporn O, Wantana P. Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study. Eur J Neurol. 2006;13(3):233\u20139.","journal-title":"Eur J Neurol"},{"issue":"3","key":"15321_CR21","first-page":"273","volume":"102","author":"P Sitticharoenchai","year":"2019","unstructured":"Sitticharoenchai P, Putcharoen O, Buddhari W. Incidence and risk factors of cardiovascular diseases among HIV patients in Thailand. J Med Assoc Thai. 2019;102(3):273\u20138.","journal-title":"J Med Assoc Thai"},{"issue":"11\u201312","key":"15321_CR22","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1089\/aid.2019.0023","volume":"35","author":"L Aurpibul","year":"2019","unstructured":"Aurpibul L, Srithanaviboonchai K, Rerkasem K, Tangmunkongvorakul A, Sitthi W, Musumari PM. Prevalence of subclinical atherosclerosis and risk of atherosclerotic Cardiovascular Disease in older adults living with HIV. AIDS Res Hum Retroviruses. 2019;35(11\u201312):1136\u201342.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"15321_CR23","first-page":"23","volume":"5","author":"O Putcharoen","year":"2019","unstructured":"Putcharoen O, Pleumkanitkul S, Chutinet A, Vongsayan P, Samajarn J, Sophonphan J, et al. Comparable carotid intima-media thickness among long-term virologically suppressed individuals with HIV and those without HIV in Thailand. J virus eradication. 2019;5(1):23\u20137.","journal-title":"J virus eradication"},{"issue":"11\u201312","key":"15321_CR24","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1089\/aid.2019.0126","volume":"35","author":"S Siwamogsatham","year":"2019","unstructured":"Siwamogsatham S, Chutinet A, Vongsayan P, Samajarn J, Putcharoen O, Aponpong T, et al. Low CD4 cell counts are Associated with Carotid Plaque and Intima-Media thickness in Virologically suppressed HIV-Infected Asians older than 50 years. AIDS Res Hum Retroviruses. 2019;35(11\u201312):1160\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"15321_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3889\/oamjms.2019.479","volume":"7","author":"S Utama","year":"2019","unstructured":"Utama S, Patriawan P, Dewi A. Correlation of CD4\/CD8 ratio with carotid intima-media layer thickness in HIV\/AIDS patients at Sanglah General Hospital, Bali, Indonesia. Open access Macedonian journal of medical sciences. 2019;7(11):1803\u20137.","journal-title":"Open access Macedonian journal of medical sciences"},{"key":"15321_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12967-015-0391-6","volume":"13","author":"R Rajasuriar","year":"2015","unstructured":"Rajasuriar R, Kong YY, Nadarajah R, Abdullah NK, Spelman T, Yuhana MY, et al. The CD14 C-260T single nucleotide polymorphism (SNP) modulates monocyte\/macrophage activation in treated HIV-infected individuals. J translational Med. 2015;13:30.","journal-title":"J translational Med"},{"issue":"1","key":"15321_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/hiv.12671","volume":"20","author":"L Aurpibul","year":"2019","unstructured":"Aurpibul L, Sugandhavesa P, Srithanaviboonchai K, Sitthi W, Tangmunkongvorakul A, Chariyalertsak C, et al. Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand. HIV Med. 2019;20(1):54\u20139.","journal-title":"HIV Med"},{"key":"15321_CR28","doi-asserted-by":"crossref","unstructured":"Nakaranurack C, Manosuthi W. Prevalence of Non-AIDS Comorbidities and Factors Associated with Metabolic Complications among HIV-infected Patients at a Thai Referral Hospital.Journal of the International Association of Providers of AIDS Care. 2018; 17.","DOI":"10.1177\/2325957417752256"},{"issue":"Suppl 2","key":"15321_CR29","first-page":"227","volume":"95","author":"B Lee","year":"2012","unstructured":"Lee B, Anekthananon T, Poungvarin N, Nilanont Y. Etiology and risk factors of stroke in HIV-infected patients in Siriraj Hospital: a case-control study. J Med Association Thailand = Chotmaihet thangphaet. 2012;95(Suppl 2):227\u201334.","journal-title":"J Med Association Thailand = Chotmaihet thangphaet"},{"issue":"11","key":"15321_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/QAD.0000000000001496","volume":"31","author":"O Putcharoen","year":"2017","unstructured":"Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, et al. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017;31(11):1535\u201343.","journal-title":"AIDS"},{"issue":"8","key":"15321_CR31","first-page":"1059","volume":"95","author":"V Peonim","year":"2012","unstructured":"Peonim V, Sujirachato K, Srisont S, Udnoon J. Pathology of HIV seropositive: forensic autopsy study in a tertiary care hospital, Bangkok, Thailand. J Med Association Thailand = Chotmaihet thangphaet. 2012;95(8):1059\u201365.","journal-title":"J Med Association Thailand = Chotmaihet thangphaet"},{"issue":"6","key":"15321_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/anec.12162","volume":"19","author":"W Wongcharoen","year":"2014","unstructured":"Wongcharoen W, Suaklin S, Tantisirivit N, Phrommintikul A, Chattipakorn N. QT dispersion in HIV-infected patients receiving combined antiretroviral therapy. Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology Inc. 2014;19(6):561\u20136.","journal-title":"Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology Inc"},{"issue":"5","key":"15321_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/anec.12064","volume":"18","author":"W Wongcharoen","year":"2013","unstructured":"Wongcharoen W, Khienprasit K, Phrommintikul A, Sukonthasarn A, Chattipakorn N. Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy. Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology Inc. 2013;18(5):450\u20136.","journal-title":"Annals of noninvasive electrocardiology: the official journal of the International Society for Holter and Noninvasive Electrocardiology Inc"},{"issue":"11","key":"15321_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.118.036211","volume":"138","author":"PY Hsue","year":"2018","unstructured":"Hsue PY, Waters DD. Time to recognize HIV infection as a Major Cardiovascular Risk factor. Circulation. 2018;138(11):1113\u20135.","journal-title":"Circulation"},{"issue":"10148","key":"15321_CR35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","volume":"392","author":"J Ghosn","year":"2018","unstructured":"Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C, Hiv. Lancet. 2018;392(10148):685\u201397.","journal-title":"Lancet"},{"issue":"5","key":"15321_CR36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.pcad.2016.02.008","volume":"58","author":"F Ballocca","year":"2016","unstructured":"Ballocca F, Gili S, D\u2019Ascenzo F, Marra WG, Cannillo M, Calcagno A, et al. HIV infection and primary Prevention of Cardiovascular Disease: lights and Shadows in the HAART era. Prog Cardiovasc Dis. 2016;58(5):565\u201376.","journal-title":"Prog Cardiovasc Dis"},{"issue":"24","key":"15321_CR37","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: Cardiovascular Disease in Diabetes Mellitus: atherosclerotic Cardiovascular Disease and Heart failure in type 2 diabetes Mellitus - Mechanisms, Management, and clinical considerations. Circulation. 2016;133(24):2459\u2013502.","journal-title":"Circulation"},{"issue":"5","key":"15321_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","volume":"34","author":"JR Petrie","year":"2018","unstructured":"Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and Cardiovascular Disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575\u201384.","journal-title":"Can J Cardiol"},{"key":"15321_CR39","doi-asserted-by":"crossref","unstructured":"Roy A, Rawal I, Jabbour S, Prabhakaran D et al. Tobacco and Cardiovascular Disease: a Summary of Evidence. In: rd, Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, editors. Cardiovascular, Respiratory, and Related Disorders. Washington (DC) 2017.","DOI":"10.1596\/978-1-4648-0518-9_ch4"},{"issue":"14","key":"15321_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jacc.2014.01.022","volume":"63","author":"CJ Lavie","year":"2014","unstructured":"Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"15321_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/eurheartj\/eht528","volume":"35","author":"LG Hemkens","year":"2014","unstructured":"Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur heart J. 2014;35(21):1373\u201381.","journal-title":"Eur heart J"},{"issue":"12","key":"15321_CR42","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","volume":"11","author":"MV Zanni","year":"2014","unstructured":"Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11(12):728\u201341.","journal-title":"Nat Rev Cardiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-15321-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-15321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:29:28Z","timestamp":1679862568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-15321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["15321"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-15321-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no completing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}